The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Substrate-targeting γ-secretase modulators
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Self-citationYang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Ab1–x was immunoprecipitated from conditioned medium with antibody 9 covalently coupled to seize beads (Pierce), with synthetic Ab40 with methionine 35 substituted by norleucine ([Nle35]-b-Amyloid(1-40); Anaspec) added as an immunoprecipitation control and mass standard.”
Self-citationBenzophenone Photophores in Biochemistry
Dorman, G., & Prestwich, G. D. (1994) · Biochemistry · doi:10.1021/bi00185a001 · Cited by 860
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Mathis, C. A., Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Hyman, B. T., Holt, D. P., Wang, Y., Huang, G.-F., Debnath, M. L., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00734-x · Cited by 403
The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain
Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 401
Self-citationIn vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe
Hintersteiner, M., Enz, A., Frey, P., Jaton, A.-L., Kinzy, W., Kneuer, R., Neumann, U., Rudin, M., Staufenbiel, M., Stoeckli, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1085 · Cited by 341
Inhibition of Alzheimer β-Fibrillogenesis by Melatonin
Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N. K., Zagorski, M., Frangione, B., & Ghiso, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7185 · Cited by 337
In Vivo Optical Imaging of Amyloid Aggregates in Brain: Design of Fluorescent Markers
Nesterov, E. E., Skoch, J., Hyman, B. T., Klunk, W. E., Bacskai, B. J., & Swager, T. M. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500845 · Cited by 336
Klunk, W. E., Wang, Y., Huang, G.-F., Debnath, M. L., Holt, D. P., Shao, L., Hamilton, R. L., Ikonomovic, M. D., DeKosky, S. T., & Mathis, C. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02086.2003 · Cited by 309
Styren, Hamilton, R. L., Styren, G. C., & Klunk, W. E. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800906 · Cited by 290
Munter, L., Voigt, P., Harmeier, A., Kaden, D., Gottschalk, K. E., Weise, C., Pipkorn, R., Schaefer, M., Langosch, D., & Multhaup, G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601616 · Cited by 285
Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production
Kukar, T., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., Ladd, T., Khan, M. A., Kache, R., Beard, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1235 · Cited by 284
Self-citationXia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 284
Self-citationWeggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303592200 · Cited by 280
Self-citationPurification and Characterization of the Human γ-Secretase Complex
Fraering, P. C., Ye, W., Strub, J.-M., Dolios, G., LaVoie, M. J., Ostaszewski, B. L., van Dorsselaer, A., Wang, R., Selkoe, D. J., & Wolfe, M. S. (2004) · Biochemistry · doi:10.1021/bi0494976 · Cited by 226
Self-citationIn vivo detection of amyloid plaques in a mouse model of Alzheimer's disease
Skovronsky, D. M., Zhang, B., Kung, M.-P., Kung, H. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7609 · Cited by 214
Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42
Chen, Y.-R., & Glabe, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602363200 · Cited by 214
Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation
Gestwicki, J. E., Crabtree, G. R., & Graef, I. A. (2004) · Science · doi:10.1126/science.1101262 · Cited by 200
Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation
Lleó, A., Berezovska, O., Herl, L., Raju, S., Deng, A., Bacskai, B. J., Frosch, M. P., Irizarry, M., & Hyman, B. T. (2004) · Nature Medicine · doi:10.1038/nm1112 · Cited by 198
Inhibitors of Amyloid Toxicity Based on β-sheet Packing of Aβ40 and Aβ42
Sato, T., Kienlen-Campard, P., Ahmed, M., Liu, W., Li, H., Elliott, J. I., Aimoto, S., Constantinescu, S. N., Octave, J.-N., & Smith, S. O. (2006) · Biochemistry · doi:10.1021/bi052485f · Cited by 191
Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., & Selkoe, D. J. (1998) · Biochemistry · doi:10.1021/bi972029u · Cited by 186
Self-citationTakahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T., & Iwatsubo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301619200 · Cited by 179
Beher, D., Clarke, E. E., Wrigley, J. D. J., Martin, A. C. L., Nadin, A., Churcher, I., & Shearman, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404937200 · Cited by 177
Murphy, M. P., Hickman, L., Eckman, C. B., Uljon, S., Wang, R., & Golde, T. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11914 · Cited by 159
Self-citationLink, C. D., Johnson, C. J., Fonte, V. G., Paupard, M., Hall, D. H., Styren, S. D., Mathis, C. A., & Klunk, W. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00237-2 · Cited by 157
Hirohata, M., Ono, K., Naiki, H., & Yamada, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.004 · Cited by 133
Structural properties of Aβ protofibrils stabilized by a small molecule
Williams, A. D., Sega, M., Chen, M., Kheterpal, I., Geva, M., Berthelier, V., Kaleta, D. T., Cook, K. D., & Wetzel, R. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408582102 · Cited by 133
Calabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.006 · Cited by 130
Self-citationChrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe
Klunk, W. E., Debnath, M. L., & Pettegrew, J. W. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00058-m · Cited by 128
Kukar, T. L., Prescott, S., Eriksen, J. L., Holloway, V. M., Murphy, M. P., Koo, E. H., Golde, T. E., & Nicolle, M. M. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-54 · Cited by 128
Self-citationAffinity-Based Inhibition of β-Amyloid Toxicity
Cairo, C. W., Strzelec, A., Murphy, R. M., & Kiessling, L. L. (2002) · Biochemistry · doi:10.1021/bi0156254 · Cited by 113
Secretion of the Notch-1 Aβ-like Peptide during Notch Signaling
Okochi, M., Fukumori, A., Jiang, J., Itoh, N., Kimura, R., Steiner, H., Haass, C., Tagami, S., & Takeda, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513250200 · Cited by 102
Schmidt, M. L., Schuck, T., Sheridan, S., Kung, M., Kung, H. F., Zhuang, Z., Bergeron, C., Lamarche, J. S., Skovronsky, D., Giasson, B. I., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61769-5 · Cited by 86
Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques
Sato, K., Higuchi, M., Iwata, N., Saido, T. C., & Sasamoto, K. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.02.013 · Cited by 82
Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease
Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C. C., Barnham, K. J., Altschul, D., Masters, C. L., Cherny, R. A., & Bush, A. I. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00196.x · Cited by 76
Mass Spectrometry-Based Screening for Inhibitors of β-Amyloid Protein Aggregation
Cheng, X., & van Breemen, R. B. (2005) · Analytical Chemistry · doi:10.1021/ac050556a · Cited by 74
A multigram chemical synthesis of the γ-secretase inhibitor LY411575 and its diastereoisomers
Fauq, A. H., Simpson, K. H., Maharvi, G. M., Golde, T. E., & Das, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.062 · Cited by 72
Self-citationControlling β-Amyloid Oligomerization by the Use of Naphthalene Sulfonates
Gonzales, A. D. F., Robbs, B. K., Moreau, V. H., Ferreira, A., Juliano, L., Valente, A. P., Almeida, F. C. L., Silva, J. L., & Foguel, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501651200 · Cited by 68
Grziwa, B., Grimm, M. O. W., Masters, C. L., Beyreuther, K. T., Hartmann, T., & Lichtenthaler, S. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210047200 · Cited by 51
Possible Mechanisms of Action of NSAIDs and Related Compounds that Modulate γ - Secretase Cleavage
Kukar, T. L., & Golde, T. E. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783334042 · Cited by 49
Self-citationChanging the Course of Alzheimer's Disease: Anti-Amyloid Disease-Modifying Treatments on the Horizon
Christensen, D. D. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0106 · Cited by 44
Narlawar, R., Pérez‐Revuelta, B. I., Haass, C., Steiner, H., Schmidt, B., & Baumann, K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0610200 · Cited by 36
Self-citationTesco, G., Ginestroni, A., Hiltunen, M. O., Kim, M., Dolios, G., Hyman, B. T., Wang, R., Berezovska, O., & Tanzi, R. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03381.x · Cited by 31
Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42
Leuchtenberger, S., Kummer, M. P., Kukar, T. L., Czirr, E., Teusch, N. E., Sagi, S. A., Berdeaux, R., Pietrzik, C. U., Ladd, T. B., Golde, T. E., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03553.x · Cited by 30
Self-citationSignal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology
Iben, L. G., Olson, R. E., Balanda, L. A., Jayachandra, S., Robertson, B., Hay, V., Corradi, J., Prasad, C. V. C., Zaczek, R. C., Albright, C. F., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707002200 · Cited by 27
Chrysamine G and its derivative reduce amyloid β-induced neurotoxicity in mice
Ishii, K., Klunk, W. E., Arawaka, S., Debnath, M. L., Furiya, Y., Sahara, N., Shoji, S., Tamaoka, A., Pettegrew, J. W., & Mori, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00915-1 · Cited by 25
Narlawar, R., Baumann, K., Czech, C., & Schmidt, B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.044 · Cited by 18
Self-citationKodadek, T. J. (2002) · Biopolymers · doi:10.1002/bip.10233 · Cited by 16
The development of molecular clamps as drugs
Weiss, S. T., McIntyre, N. R., McLaughlin, M. L., & Merkler, D. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.011 · Cited by 11
Cited by
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,064
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
Self-citation
Metadata
- Authors
- Kukar, T. L., Ladd, T. B., Bann, M. A., Fraering, P. C., Narlawar, R., Maharvi, G. M., Healy, B., Chapman, R., Welzel, A. T., Price, R. W., Moore, B., Rangachari, V., Cusack, B., Eriksen, J., Jansen-West, K., Verbeeck, C., Yager, D., Eckman, C., Ye, W., Sagi, S., Cottrell, B. A., Torpey, J., Rosenberry, T. L., Fauq, A., Wolfe, M. S., Schmidt, B., Walsh, D. M., Koo, E. H., & Golde, T. E.
- Venue
- Nature
- Published
- 2008-06
- Volume
- 453
- Issue
- 7197
- Pages
- 925-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1861730929
- Cited by
- 280
- References
- 51
- FWCI
- 27.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.